PTEN_CANLF
ID PTEN_CANLF Reviewed; 403 AA.
AC P60483; O00633; O02679;
DT 16-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT 16-FEB-2004, sequence version 1.
DT 03-AUG-2022, entry version 135.
DE RecName: Full=Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN;
DE EC=3.1.3.16 {ECO:0000250|UniProtKB:P60484};
DE EC=3.1.3.48 {ECO:0000250|UniProtKB:P60484};
DE EC=3.1.3.67 {ECO:0000250|UniProtKB:P60484};
DE AltName: Full=Mutated in multiple advanced cancers 1;
DE AltName: Full=Phosphatase and tensin homolog;
GN Name=PTEN; Synonyms=MMAC1;
OS Canis lupus familiaris (Dog) (Canis familiaris).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; Canis.
OX NCBI_TaxID=9615;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=9090379; DOI=10.1038/ng0497-356;
RA Steck P.A., Pershouse M.A., Jasser S.A., Lin H., Yung W.K.A., Ligon A.H.,
RA Langford L.A., Baumgard M.L., Hattier T., Davis T., Frye C., Hu R.,
RA Swedlund B., Teng D.H.-F., Tavtigian S.V.;
RT "Identification of a candidate tumour suppressor gene, MMAC1, at chromosome
RT 10q23.3 that is mutated in multiple advanced cancers.";
RL Nat. Genet. 15:356-363(1997).
CC -!- FUNCTION: Tumor suppressor. Acts as a dual-specificity protein
CC phosphatase, dephosphorylating tyrosine-, serine- and threonine-
CC phosphorylated proteins. Also acts as a lipid phosphatase, removing the
CC phosphate in the D3 position of the inositol ring from
CC phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3,4-
CC diphosphate, phosphatidylinositol 3-phosphate and inositol 1,3,4,5-
CC tetrakisphosphate with order of substrate preference in vitro
CC PtdIns(3,4,5)P3 > PtdIns(3,4)P2 > PtdIns3P > Ins(1,3,4,5)P4. The lipid
CC phosphatase activity is critical for its tumor suppressor function.
CC Antagonizes the PI3K-AKT/PKB signaling pathway by dephosphorylating
CC phosphoinositides and thereby modulating cell cycle progression and
CC cell survival. The unphosphorylated form cooperates with MAGI2 to
CC suppress AKT1 activation. Dephosphorylates tyrosine-phosphorylated
CC focal adhesion kinase and inhibits cell migration and integrin-mediated
CC cell spreading and focal adhesion formation. Plays a role as a key
CC modulator of the AKT-mTOR signaling pathway controlling the tempo of
CC the process of newborn neurons integration during adult neurogenesis,
CC including correct neuron positioning, dendritic development and synapse
CC formation. May be a negative regulator of insulin signaling and glucose
CC metabolism in adipose tissue. The nuclear monoubiquitinated form
CC possesses greater apoptotic potential, whereas the cytoplasmic
CC nonubiquitinated form induces less tumor suppressive ability. In motile
CC cells, suppresses the formation of lateral pseudopods and thereby
CC promotes cell polarization and directed movement (By similarity).
CC {ECO:0000250|UniProtKB:P60484}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-
CC trisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC inositol-4,5-bisphosphate) + phosphate; Xref=Rhea:RHEA:25017,
CC ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:57836,
CC ChEBI:CHEBI:58456; EC=3.1.3.67;
CC Evidence={ECO:0000250|UniProtKB:P60484};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] +
CC phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474,
CC ChEBI:CHEBI:83421; EC=3.1.3.16;
CC Evidence={ECO:0000250|UniProtKB:P60484};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] +
CC phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474,
CC ChEBI:CHEBI:61977; EC=3.1.3.16;
CC Evidence={ECO:0000250|UniProtKB:P60484};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC ChEBI:CHEBI:82620; EC=3.1.3.48;
CC Evidence={ECO:0000250|UniProtKB:P60484};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=1,2-dioctanoyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-
CC trisphosphate) + H2O = 1,2-dioctanoyl-sn-glycero-3-phospho-(1D-myo-
CC inositol-4,5-bisphosphate) + phosphate; Xref=Rhea:RHEA:43552,
CC ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:83416,
CC ChEBI:CHEBI:83419; Evidence={ECO:0000250|UniProtKB:P60484};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=1,2-dihexadecanoyl-sn-glycero-3-phospho-(1D-myo-inositol-
CC 3,4,5-trisphosphate) + H2O = 1,2-dihexadecanoyl-sn-glycero-3-phospho-
CC (1D-myo-inositol-4,5-bisphosphate) + phosphate; Xref=Rhea:RHEA:43560,
CC ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:83420,
CC ChEBI:CHEBI:83423; Evidence={ECO:0000250|UniProtKB:P60484};
CC -!- COFACTOR:
CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC -!- SUBUNIT: Monomer. The unphosphorylated form interacts with the second
CC PDZ domain of MAGI2 and with DLG1 and MAST2 in vitro. Interacts with
CC MAGI2, MAGI3, MAST1 and MAST3, but neither with MAST4 nor with DLG5;
CC interaction with MAGI2 increases protein stability. Interacts with
CC NEDD4. Interacts with NDFIP1 and NDFIP2; in the presence of NEDD4 or
CC ITCH, this interaction promotes PTEN ubiquitination. Interacts (via C2
CC domain) with FRK. Interacts with USP7; the interaction is direct (By
CC similarity). Interacts with ROCK1 (By similarity). Interacts with
CC XIAP/BIRC4. Interacts with STK11; the interaction phosphorylates PTEN.
CC Interacts with PPP1R16B (By similarity). Interacts with NOP53;
CC regulates PTEN phosphorylation and increases its stability.
CC {ECO:0000250|UniProtKB:O08586, ECO:0000250|UniProtKB:P60484}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P60484}. Nucleus
CC {ECO:0000250|UniProtKB:P60484}. Nucleus, PML body
CC {ECO:0000250|UniProtKB:P60484}. Note=Monoubiquitinated form is nuclear.
CC Nonubiquitinated form is cytoplasmic. Colocalized with PML and USP7 in
CC PML nuclear bodies. XIAP/BIRC4 promotes its nuclear localization.
CC {ECO:0000250|UniProtKB:P60484}.
CC -!- PTM: Constitutively phosphorylated by CK2 under normal conditions.
CC Phosphorylation results in an inhibited activity towards PIP3.
CC Phosphorylation can both inhibit or promote PDZ-binding.
CC Phosphorylation at Tyr-336 by FRK/PTK5 protects this protein from
CC ubiquitin-mediated degradation probably by inhibiting its binding to
CC NEDD4. Phosphorylation by ROCK1 is essential for its stability and
CC activity. Phosphorylation by PLK3 promotes its stability and prevents
CC its degradation by the proteasome (By similarity). {ECO:0000250}.
CC -!- PTM: Monoubiquitinated; monoubiquitination is increased in presence of
CC retinoic acid. Deubiquitinated by USP7; leading to its nuclear
CC exclusion. Monoubiquitination of one of either Lys-13 and Lys-289 amino
CC acid is sufficient to modulate PTEN compartmentalization (By
CC similarity). Ubiquitinated by XIAP/BIRC4 (By similarity).
CC {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the PTEN phosphatase protein family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; U92435; AAC48709.1; -; mRNA.
DR RefSeq; NP_001003192.1; NM_001003192.1.
DR AlphaFoldDB; P60483; -.
DR SMR; P60483; -.
DR STRING; 9615.ENSCAFP00000045099; -.
DR PaxDb; P60483; -.
DR Ensembl; ENSCAFT00030039048; ENSCAFP00030034056; ENSCAFG00030021263.
DR Ensembl; ENSCAFT00040044339; ENSCAFP00040038712; ENSCAFG00040023806.
DR Ensembl; ENSCAFT00845052143; ENSCAFP00845040898; ENSCAFG00845029443.
DR GeneID; 403832; -.
DR KEGG; cfa:403832; -.
DR CTD; 5728; -.
DR VEuPathDB; HostDB:ENSCAFG00845029443; -.
DR eggNOG; KOG2283; Eukaryota.
DR GeneTree; ENSGT00940000154335; -.
DR InParanoid; P60483; -.
DR OrthoDB; 639380at2759; -.
DR Proteomes; UP000002254; Chromosome 26.
DR GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR GO; GO:0042995; C:cell projection; IBA:GO_Central.
DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR GO; GO:0009898; C:cytoplasmic side of plasma membrane; IEA:Ensembl.
DR GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR GO; GO:0035749; C:myelin sheath adaxonal region; IEA:Ensembl.
DR GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR GO; GO:0043220; C:Schmidt-Lanterman incisure; IEA:Ensembl.
DR GO; GO:0045202; C:synapse; IEA:GOC.
DR GO; GO:0010997; F:anaphase-promoting complex binding; IEA:Ensembl.
DR GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR GO; GO:0051717; F:inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity; ISS:UniProtKB.
DR GO; GO:0017018; F:myosin phosphatase activity; IEA:UniProtKB-EC.
DR GO; GO:0030165; F:PDZ domain binding; ISS:UniProtKB.
DR GO; GO:0016314; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; ISS:UniProtKB.
DR GO; GO:0051800; F:phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity; ISS:UniProtKB.
DR GO; GO:0004438; F:phosphatidylinositol-3-phosphatase activity; ISS:UniProtKB.
DR GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR GO; GO:0004722; F:protein serine/threonine phosphatase activity; ISS:UniProtKB.
DR GO; GO:0004725; F:protein tyrosine phosphatase activity; ISS:UniProtKB.
DR GO; GO:1990381; F:ubiquitin-specific protease binding; IEA:Ensembl.
DR GO; GO:0030534; P:adult behavior; IEA:Ensembl.
DR GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR GO; GO:0042100; P:B cell proliferation; IEA:Ensembl.
DR GO; GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl.
DR GO; GO:0048738; P:cardiac muscle tissue development; IEA:Ensembl.
DR GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR GO; GO:0048870; P:cell motility; IBA:GO_Central.
DR GO; GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl.
DR GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR GO; GO:0007417; P:central nervous system development; ISS:UniProtKB.
DR GO; GO:0032286; P:central nervous system myelin maintenance; IEA:Ensembl.
DR GO; GO:0021955; P:central nervous system neuron axonogenesis; IEA:Ensembl.
DR GO; GO:0060997; P:dendritic spine morphogenesis; IEA:Ensembl.
DR GO; GO:0021542; P:dentate gyrus development; IEA:Ensembl.
DR GO; GO:0016311; P:dephosphorylation; IBA:GO_Central.
DR GO; GO:0043542; P:endothelial cell migration; IEA:Ensembl.
DR GO; GO:0048853; P:forebrain morphogenesis; IEA:Ensembl.
DR GO; GO:0007507; P:heart development; ISS:UniProtKB.
DR GO; GO:0046855; P:inositol phosphate dephosphorylation; ISS:UniProtKB.
DR GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR GO; GO:0045475; P:locomotor rhythm; IEA:Ensembl.
DR GO; GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl.
DR GO; GO:0060179; P:male mating behavior; IEA:Ensembl.
DR GO; GO:0042711; P:maternal behavior; IEA:Ensembl.
DR GO; GO:0033555; P:multicellular organismal response to stress; IEA:Ensembl.
DR GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR GO; GO:0048681; P:negative regulation of axon regeneration; IEA:Ensembl.
DR GO; GO:0050771; P:negative regulation of axonogenesis; IEA:Ensembl.
DR GO; GO:0030889; P:negative regulation of B cell proliferation; IEA:Ensembl.
DR GO; GO:0060044; P:negative regulation of cardiac muscle cell proliferation; IEA:Ensembl.
DR GO; GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB.
DR GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR GO; GO:0045792; P:negative regulation of cell size; IEA:Ensembl.
DR GO; GO:2000773; P:negative regulation of cellular senescence; IEA:Ensembl.
DR GO; GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl.
DR GO; GO:0061002; P:negative regulation of dendritic spine morphogenesis; IEA:Ensembl.
DR GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.
DR GO; GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IEA:Ensembl.
DR GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR GO; GO:0090394; P:negative regulation of excitatory postsynaptic potential; IEA:Ensembl.
DR GO; GO:0051895; P:negative regulation of focal adhesion assembly; ISS:UniProtKB.
DR GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR GO; GO:0051548; P:negative regulation of keratinocyte migration; IEA:Ensembl.
DR GO; GO:0031642; P:negative regulation of myelination; IEA:Ensembl.
DR GO; GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IEA:Ensembl.
DR GO; GO:0051898; P:negative regulation of protein kinase B signaling; ISS:UniProtKB.
DR GO; GO:0090071; P:negative regulation of ribosome biogenesis; IEA:Ensembl.
DR GO; GO:2000808; P:negative regulation of synaptic vesicle clustering; IEA:Ensembl.
DR GO; GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl.
DR GO; GO:1904706; P:negative regulation of vascular associated smooth muscle cell proliferation; IEA:Ensembl.
DR GO; GO:1903690; P:negative regulation of wound healing, spreading of epidermal cells; IEA:Ensembl.
DR GO; GO:0007270; P:neuron-neuron synaptic transmission; IEA:Ensembl.
DR GO; GO:0014065; P:phosphatidylinositol 3-kinase signaling; IBA:GO_Central.
DR GO; GO:0046856; P:phosphatidylinositol dephosphorylation; ISS:UniProtKB.
DR GO; GO:0008284; P:positive regulation of cell population proliferation; IEA:Ensembl.
DR GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; IEA:Ensembl.
DR GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IEA:Ensembl.
DR GO; GO:1903984; P:positive regulation of TRAIL-activated apoptotic signaling pathway; IEA:Ensembl.
DR GO; GO:1904668; P:positive regulation of ubiquitin protein ligase activity; IEA:Ensembl.
DR GO; GO:2000060; P:positive regulation of ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR GO; GO:0097107; P:postsynaptic density assembly; IEA:Ensembl.
DR GO; GO:0060134; P:prepulse inhibition; IEA:Ensembl.
DR GO; GO:0097105; P:presynaptic membrane assembly; IEA:Ensembl.
DR GO; GO:0060736; P:prostate gland growth; IEA:Ensembl.
DR GO; GO:0006470; P:protein dephosphorylation; ISS:UniProtKB.
DR GO; GO:0043491; P:protein kinase B signaling; ISS:UniProtKB.
DR GO; GO:0050821; P:protein stabilization; IEA:Ensembl.
DR GO; GO:0002902; P:regulation of B cell apoptotic process; IEA:Ensembl.
DR GO; GO:0060341; P:regulation of cellular localization; IEA:Ensembl.
DR GO; GO:2000109; P:regulation of macrophage apoptotic process; IEA:Ensembl.
DR GO; GO:0010975; P:regulation of neuron projection development; ISS:UniProtKB.
DR GO; GO:0051896; P:regulation of protein kinase B signaling; IBA:GO_Central.
DR GO; GO:0031647; P:regulation of protein stability; ISS:UniProtKB.
DR GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl.
DR GO; GO:0060024; P:rhythmic synaptic transmission; IEA:Ensembl.
DR GO; GO:0035176; P:social behavior; IEA:Ensembl.
DR GO; GO:0060074; P:synapse maturation; IEA:Ensembl.
DR GO; GO:0042098; P:T cell proliferation; IEA:Ensembl.
DR CDD; cd14509; PTP_PTEN; 1.
DR Gene3D; 3.90.190.10; -; 1.
DR InterPro; IPR017361; Bifunc_PIno_P3_Pase/Pase_PTEN.
DR InterPro; IPR035892; C2_domain_sf.
DR InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR InterPro; IPR045101; PTP_PTEN.
DR InterPro; IPR014020; Tensin_C2-dom.
DR InterPro; IPR029023; Tensin_phosphatase.
DR InterPro; IPR016130; Tyr_Pase_AS.
DR InterPro; IPR003595; Tyr_Pase_cat.
DR InterPro; IPR000387; Tyr_Pase_dom.
DR Pfam; PF10409; PTEN_C2; 1.
DR PIRSF; PIRSF038025; PTEN; 1.
DR SMART; SM01326; PTEN_C2; 1.
DR SMART; SM00404; PTPc_motif; 1.
DR SUPFAM; SSF49562; SSF49562; 1.
DR SUPFAM; SSF52799; SSF52799; 1.
DR PROSITE; PS51182; C2_TENSIN; 1.
DR PROSITE; PS51181; PPASE_TENSIN; 1.
PE 2: Evidence at transcript level;
KW Acetylation; Apoptosis; Cytoplasm; Hydrolase; Isopeptide bond;
KW Lipid metabolism; Neurogenesis; Nucleus; Phosphoprotein;
KW Protein phosphatase; Reference proteome; Tumor suppressor; Ubl conjugation.
FT INIT_MET 1
FT /note="Removed"
FT /evidence="ECO:0000250|UniProtKB:P60484"
FT CHAIN 2..403
FT /note="Phosphatidylinositol 3,4,5-trisphosphate 3-
FT phosphatase and dual-specificity protein phosphatase PTEN"
FT /id="PRO_0000215903"
FT DOMAIN 14..185
FT /note="Phosphatase tensin-type"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00590"
FT DOMAIN 190..350
FT /note="C2 tensin-type"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00589"
FT REGION 338..348
FT /note="Required for interaction with NOP53"
FT /evidence="ECO:0000250|UniProtKB:P60484"
FT REGION 352..403
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 401..403
FT /note="PDZ domain-binding"
FT /evidence="ECO:0000250"
FT COMPBIAS 353..370
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 371..385
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT ACT_SITE 124
FT /note="Phosphocysteine intermediate"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00590"
FT MOD_RES 2
FT /note="N-acetylthreonine"
FT /evidence="ECO:0000250|UniProtKB:P60484"
FT MOD_RES 294
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O08586"
FT MOD_RES 336
FT /note="Phosphotyrosine; by FRK"
FT /evidence="ECO:0000250|UniProtKB:P60484"
FT MOD_RES 366
FT /note="Phosphothreonine; by GSK3-beta and PLK3"
FT /evidence="ECO:0000250|UniProtKB:P60484"
FT MOD_RES 370
FT /note="Phosphoserine; by CK2 and PLK3"
FT /evidence="ECO:0000250|UniProtKB:P60484"
FT MOD_RES 380
FT /note="Phosphoserine; by ROCK1"
FT /evidence="ECO:0000250|UniProtKB:P60484"
FT MOD_RES 382
FT /note="Phosphothreonine; by ROCK1"
FT /evidence="ECO:0000250|UniProtKB:P60484"
FT MOD_RES 383
FT /note="Phosphothreonine; by ROCK1"
FT /evidence="ECO:0000250|UniProtKB:P60484"
FT MOD_RES 385
FT /note="Phosphoserine; by CK2"
FT /evidence="ECO:0000250|UniProtKB:P60484"
FT MOD_RES 401
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250|UniProtKB:P60484"
FT CROSSLNK 13
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in ubiquitin)"
FT /evidence="ECO:0000250|UniProtKB:P60484"
FT CROSSLNK 289
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in ubiquitin)"
FT /evidence="ECO:0000250|UniProtKB:P60484"
SQ SEQUENCE 403 AA; 47166 MW; 75F97C3DD6802BA9 CRC64;
MTAIIKEIVS RNKRRYQEDG FDLDLTYIYP NIIAMGFPAE RLEGVYRNNI DDVVRFLDSK
HKNHYKIYNL CAERHYDTAK FNCRVAQYPF EDHNPPQLEL IKPFCEDLDQ WLSEDDNHVA
AIHCKAGKGR TGVMICAYLL HRGKFLKAQE ALDFYGEVRT RDKKGVTIPS QRRYVYYYSY
LLKNHLDYRP VALLFHKMMF ETIPMFSGGT CNPQFVVCQL KVKIYSSNSG PTRREDKFMY
FEFPQPLPVC GDIKVEFFHK QNKMLKKDKM FHFWVNTFFI PGPEETSEKV ENGSLCDQEI
DSICSIERAD NDKEYLVLTL TKNDLDKANK DKANRYFSPN FKVKLYFTKT VEEPSNPEAS
SSTSVTPDVS DNEPDHYRYS DTTDSDPENE PFDEDQHTQI TKV
